Hong Tian

China Pharmaceutical University

H指数:25

被引数:2,212

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design and evaluation of pectin-based nanoparticles for overcoming biological barriers as insulin carriers with oral administration potential

基于果胶的纳米颗粒的设计与评价：作为具有口服给药潜力的胰岛素载体以克服生物屏障

Food Research International

IF8

2026-08-150

PRE

Histone delactylation shapes epigenetic landscapes and therapeutic stratification in hepatocellular carcinoma

组蛋白去乳酰化重塑肝癌的表观遗传景观和治疗分层

iLiver

IF0

2026-05-011

OAAI

The Impact of Hepatitis B Virus on the Tumor Microenvironment of Hepatocellular Carcinoma and Therapeutic Strategies

乙型肝炎病毒对肝细胞癌肿瘤微环境的影响及治疗策略

Journal of Gastroenterology and Hepatology

IF3.4

2026-02-240

OAAI

Preparation of nanoparticles from atmospheric pressure plasma jet-activated gas modified pectin for oral insulin delivery

Carbohydrate Polymers

IF12.5

2026-01-230

PRE

Monitoring Overall Survival in Phase 3 Indolent Cancers: An Extended Framework and an Example

监测III期惰性癌症的总生存期：一个扩展框架及一个实例

Statistics in Biopharmaceutical Research

IF1.3

2025-11-010

PRE

Periodontitis Promotes OSCC and Prostate Cancer Progression and Immunosuppression by Skewing Myeloid Differentiation of HSPCs

牙周炎通过偏移HSPCs的髓系分化来促进OSCC和前列腺癌的进展及免疫抑制

Journal of Dental Research

IF5.9

2025-10-180

PRE

Stabilization of chitosan-based nanomedicines in cancer therapy: a review

壳聚糖基纳米药物在癌症治疗中的稳定化：综述

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

IF8.5

2025-05-010

PRE

Restoring tumor antigenicity activates the bystander T cell immune cycle

恢复肿瘤抗原性激活旁观者T细胞免疫循环

JOURNAL OF CONTROLLED RELEASE

IF11.5

2025-04-010

PRE

Nitrated T cell epitope linked vaccine targeting CD47 elicits antitumor immune responses and acts synergistically with vaccine targeting PDL1

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-02-010

PRE

Association between 5-HTTLPR and STin2 VNTR polymorphisms in the serotonin transporter gene and clinical response of a selective serotonin reuptake inhibitor (dapoxetine) in lifelong premature ejaculation

CHINESE MEDICAL JOURNAL

IF7.3

2022-07-050

OAAI

Safety and Efficacy of Systemic Anti-Scg3 Therapy to Treat Oxygen-Induced Retinopathy

FRONTIERS IN BIOSCIENCE-LANDMARK

IF3.1

2022-04-195

Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation

TRANSPLANTATION AND CELLULAR THERAPY

IF4.4

2022-03-0113

OAAI

An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice

口服GLP-1和GIP双受体激动剂改善高脂喂养小鼠的代谢紊乱

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2022-01-0110

PRE

The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2021-09-0415

OAAI

A purified acidic polysaccharide from Sarcandra glabra as vaccine adjuvant to enhance anti-tumor effect of cancer vaccine

CARBOHYDRATE POLYMERS

IF12.5

2021-07-0121

PREAI

Light-Controlled Tyrosine Nitration of Proteins

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2021-05-1040

PREAI

PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses (vol 476, pg 170, 2020)

CANCER LETTERS

IF10.1

2021-02-010

PREAI

A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction

BIOCHEMICAL PHARMACOLOGY

IF5.6

2020-12-0125

PREAI

An orally available hypoglycaemic peptide taken up by caveolae transcytosis displays improved hypoglycaemic effects and body weight control in db/db mice

BRITISH JOURNAL OF PHARMACOLOGY

IF7.7

2020-06-074

OAAI

PDL1-targeted vaccine exhibits potent antitumor activity by simultaneously blocking PD1/PDL1 pathway and activating PDL1-specific immune responses

CANCER LETTERS

IF10.1

2020-04-0127

PREAI

Hong Tian

个人简介

教育背景

工作经历

荣誉奖项

研究方向